Extensive Use of Interventional Therapies Improves Survival in Unresectable or Recurrent Intrahepatic Cholangiocarcinoma

<div>Overall survival rate in all patients from time of first diagnosis (a) and from time of first therapy at our institution (b). Median overall survival from time of first diagnosis: 33.1 months (95% CI 16.5–49.8 months). Median overall survival from time of first therapy at our institution: 16.0 months (95% CI 8.8–32.2 months).</div>

Gastroenterology Research and Practice

fig2

Figure 2

Figure 2: Extensive Use of Interventional Therapies Improves Survival in Unresectable or Recurrent Intrahepatic Cholangiocarcinoma 